Shahin Jamal
YOU?
Author Swipe
View article: 400 New ICD code-based case definition correctly identifies ICI-IA from administrative health data
400 New ICD code-based case definition correctly identifies ICI-IA from administrative health data Open
View article: <b>Spectrum of Neurological Disorders in Patients Visiting Tertiary Care Hospitals in Peshawar</b>
<b>Spectrum of Neurological Disorders in Patients Visiting Tertiary Care Hospitals in Peshawar</b> Open
Background: Neurological disorders represent a major cause of global morbidity and disability, particularly in low- and middle-income countries where epidemiological data remain limited. Pakistan faces a growing burden of epilepsy, headach…
View article: Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases Open
Objective Although immune checkpoint inhibitors (ICIs) are increasingly used in patients with preexisting systemic autoimmune rheumatic diseases (SARDs), a key concern is whether baseline immunosuppression at the start of ICI treatment mig…
View article: Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides Open
Objective Immune checkpoint inhibitors (ICIs) are being increasingly used in patients with preexisting inflammatory arthritides (IAs). However, there are concerns that concomitant baseline immunosuppression at the time of ICI initiation ma…
View article: Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment
Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment Open
View article: Immune Checkpoint Inhibitors: A Pediatric Needs Assessment
Immune Checkpoint Inhibitors: A Pediatric Needs Assessment Open
Objectives Immune checkpoint inhibitor (ICI) therapy is increasing in pediatric oncology. Immune-related adverse events (irAEs) can affect various organ systems, including rheumatic-irAEs (Rh-irAEs) such as inflammatory arthritis, myositis…
View article: Certolizumab Inhibits Radiographic Progression Even in Rheumatoid Arthritis Patients with High Rheumatoid Factor Levels: A Pooled, Post Hoc Analysis of Two Phase 3 Trials
Certolizumab Inhibits Radiographic Progression Even in Rheumatoid Arthritis Patients with High Rheumatoid Factor Levels: A Pooled, Post Hoc Analysis of Two Phase 3 Trials Open
Objectives To assess radiographic progression in certolizumab pegol (CZP)+methotrexate (MTX) vs placebo (PBO)+MTX-treated patients (pts) with rheumatoid arthritis (RA), stratified by rheumatoid factor (RF) level, in the C-EARLY ( NCT015197…
View article: Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series
Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series Open
Objectives Immune checkpoint inhibitors (ICIs) are a revolutionary cancer treatment that block inhibition of T cells, promoting immune-mediated clearance of malignancies. Decreased regulation of T cells can have many off-target effects, in…
View article: Confidence Check: Closing the Educational Gaps in Immune Checkpoint Inhibitors
Confidence Check: Closing the Educational Gaps in Immune Checkpoint Inhibitors Open
Objectives The growing use of immune checkpoint inhibitors (ICIs) in pediatric oncology has introduced pediatric rheumatologists (PR) to immune-related adverse events (irAEs), including rheumatic-irAEs (Rh-irAEs).[1] These novel conditions…
View article: OP0182 BASELINE IMMUNOSUPPRESSION AND CANCER SURVIVAL IN PATIENTS WITH PRE-EXISTING RHEUMATIC DISEASE TREATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO)
OP0182 BASELINE IMMUNOSUPPRESSION AND CANCER SURVIVAL IN PATIENTS WITH PRE-EXISTING RHEUMATIC DISEASE TREATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) Open
View article: Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy?
Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? Open
View article: Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? New Iatrogenic Disease Case Series From CanRIO
Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? New Iatrogenic Disease Case Series From CanRIO Open
View article: AWARENESS AND ATTITUDE OF PATIENTS TOWARDS RADIATION EXPOSURE IN TERTIARY CARE HOSPITALS
AWARENESS AND ATTITUDE OF PATIENTS TOWARDS RADIATION EXPOSURE IN TERTIARY CARE HOSPITALS Open
Background: Radiation exposure, particularly ionizing radiation, is a significant concern in medical imaging. Understanding patient awareness of radiation risks is crucial for improving healthcare practices. Although previous studies have …
View article: Environmental and Genetic Etiology of Rheumatoid Arthritis
Environmental and Genetic Etiology of Rheumatoid Arthritis Open
Rheumatoid arthritis (RA) is a chronic inflammatory disorder affecting joints, characterized by pain, stiffness, and limited mobility. Through a meticulous evaluation of recent studies, this review explores emerging molecular and cellular …
View article: Improving Knowledge Dissemination of Rheumatic Toxicities of Cancer Immunotherapy: A Web‐Based Educational Initiative
Improving Knowledge Dissemination of Rheumatic Toxicities of Cancer Immunotherapy: A Web‐Based Educational Initiative Open
View article: Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography
Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography Open
View article: Chronicity of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno‐Oncology Database
Chronicity of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno‐Oncology Database Open
Objective Immune checkpoint inhibitors (ICIs) improve overall survival (OS) and progression‐free survival (PFS) in many types of malignancies but can result in off‐target immune‐related adverse events including inflammatory arthritis (ICI‐…
View article: Predictors of depression trajectories during the COVID-19 pandemic in adults with rheumatoid arthritis: results from the Canadian Early Arthritis Cohort
Predictors of depression trajectories during the COVID-19 pandemic in adults with rheumatoid arthritis: results from the Canadian Early Arthritis Cohort Open
Objectives Growing evidence points to mental health impacts of coronavirus disease 2019 (COVID-19). We explored trajectories of depressive symptoms in the year pre- and 2 years post-pandemic onset in adults with RA. Methods Data are from t…
View article: TALE-teller: Tendon-Actuated Linked Element Robotic Testbed for Investigating Tail Functions
TALE-teller: Tendon-Actuated Linked Element Robotic Testbed for Investigating Tail Functions Open
Tails serve various functions in both robotics and biology, including expression, grasping, and defense. The vertebrate tails associated with these functions exhibit diverse patterns of vertebral lengths, but the precise mechanisms linking…
View article: Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort
Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort Open
Objective Hypertension (HTN) is a common comorbidity in RA. This study aimed to explore the prevalence and incidence of HTN and baseline factors associated with incident HTN in early RA (ERA). Methods Data were from the Canadian Early Arth…
View article: 174 Functional Outcomes in Older Patients Following Major Limb Amputation
174 Functional Outcomes in Older Patients Following Major Limb Amputation Open
Aim More than 5,000 major limb amputations (MLA) are performed annually in the United Kingdom. The relationship between medical co-morbidity and frailty is complex and can have an adverse effect on both mortality and functional capacity. T…
View article: Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1 Open
We have updated the Canadian Rheumatology Association (CRA) guidelines for rheumatoid arthritis, with a series of best practice statements and a recommendation for the choice of disease-modifying antirheumatic drug therapy after an inadequ…
View article: POS1567 OUTCOMES AND PREDICTORS OF CHRONIC IMMUNE CHECKPOINT INHIBITOR INDUCED INFLAMMATORY ARTHRITIS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) RETROSPECTIVE COHORT
POS1567 OUTCOMES AND PREDICTORS OF CHRONIC IMMUNE CHECKPOINT INHIBITOR INDUCED INFLAMMATORY ARTHRITIS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) RETROSPECTIVE COHORT Open
View article: AB1768-HPR SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATIC AUTOIMMUNE DISEASE: EXPERIENCE FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO)
AB1768-HPR SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATIC AUTOIMMUNE DISEASE: EXPERIENCE FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) Open
View article: Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group Open
View article: POS1361 THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CanRIO): A NATIONWIDE MULTI-CENTER PROSPECTIVE COHORT
POS1361 THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CanRIO): A NATIONWIDE MULTI-CENTER PROSPECTIVE COHORT Open
View article: Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study Open
This work was supported by a gift donation from Hsu & Taylor Family to the VGH Foundation, and the Yale Bernard G. Forget Scholarship.
View article: IgG4-related prostatitis manifesting as urinary obstruction in a 28-year-old male
IgG4-related prostatitis manifesting as urinary obstruction in a 28-year-old male Open
View article: Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome Open
View article: Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology Open